Lymph stasis promotes tumor growth.

[1]  E. Ruocco,et al.  Mucinous adenocarcinoma in association with hidradenitis suppurativa: a new example of isoscartopic response , 2018, Clinical and experimental dermatology.

[2]  Y. Fujisawa,et al.  Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. , 2017, Journal of dermatological science.

[3]  A. Grada,et al.  Lymphedema: Pathophysiology and clinical manifestations. , 2017, Journal of the American Academy of Dermatology.

[4]  E. Ruocco,et al.  The concept of immunocompromised district might explain the carcinogenic progression in hidradenitis suppurativa , 2017, Acta oncologica.

[5]  E. Ruocco,et al.  Letter to the Editor referring to Hessam et al. – Squamous cell carcinoma arising in hidradenitis suppurativa: subclinical lymphedema may have favored the tumor onset , 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[6]  G. Fabbrocini,et al.  Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: An overlooked facet of the immunocompromised district. , 2017, Clinics in dermatology.

[7]  T. Russo,et al.  Ruocco's immunocompromised cutaneous district , 2016, International journal of dermatology.

[8]  V. Piccolo,et al.  The immunocompromised district in dermatology: A unifying pathogenic view of the regional immune dysregulation. , 2014, Clinics in dermatology.

[9]  R. Wolf,et al.  Opportunistic localization of skin lesions on vulnerable areas. , 2011, Clinics in dermatology.

[10]  V. Ruocco,et al.  The immunocompromised district: a unifying concept for lymphoedematous, herpes‐infected and otherwise damaged sites , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  V. Ruocco,et al.  Lymphedematous areas: privileged sites for tumors, infections, and immune disorders , 2007, International journal of dermatology.

[12]  R. Schwartz,et al.  Lymphedema: an immunologically vulnerable site for development of neoplasms. , 2002, Journal of the American Academy of Dermatology.